MAPT and early-onset autosomal dominant Alzheimer disease: Given that RFX7 has been associated with Alzheimer’s disease [13] and cognitive function [14, 15], a particularly interesting candidate target is SNYPO encoding for the actin filament regulator synaptopodin, which is important for synaptic plasticity [41, 42] and can facilitate Tau protein degradation [43].